Predictive Value of Different Expressions of Forced Expiratory Volume in 1 Second (FEV1) for Adverse Outcomes in a Cohort of Adults Aged 80 and Older
- PMID: 27751804
- DOI: 10.1016/j.jamda.2016.08.012
Predictive Value of Different Expressions of Forced Expiratory Volume in 1 Second (FEV1) for Adverse Outcomes in a Cohort of Adults Aged 80 and Older
Abstract
Objectives: Forced expiratory volume in 1 second (FEV1) is proposed as a marker of healthy ageing and FEV1 expressions that are independent of reference values have been reported to be better at predicting mortality in older adults. We assess and compare the predictive value of different FEV1 expressions for mortality, hospitalization, and physical and mental decline in adults aged 80 and older.
Design: Population-based, prospective, cohort study.
Setting: The BELFRAIL study, Belgium.
Participants: A total of 501 community-dwelling adults aged 80 and older (mean age 84.7 years).
Measurements: Baseline FEV1 expressed as percent predicted (FEV1PP) and z-score (FEV1Z) using the Global Lung Function Initiative 2012 reference values; over lowest sex-specific percentile (FEV1Q), and height squared (FEV1/Ht2) and cubed (FEV1/Ht3). Mortality data until 5.1 ± 0.2 years from baseline; hospitalization data until 3.0 ± 0.25 years. Activities of daily living, battery of physical performance tests, Mini-Mental State Examination, and 15-item Geriatric Depression Scale at baseline and after 1.7 ± 0.2 years.
Results: Individuals in the lowest quartile of FEV1 expressions had higher adjusted risk than the rest of study population for all-cause mortality (highest hazard ratio 2.05 [95% Confidence Interval 1.50-2.80] for FEV1Q and 2.01 [1.47-2.76] for FEV1/Ht3), first hospitalization (highest hazard ratio 1.63 [1.21-2.16] for FEV1/Ht2 and 1.61[1.20-2.16] for FEV1/Ht3), mental decline (highest odds ratio 2.80 [1.61-4.89] for FEV1Q) and physical decline (only FEV1/Ht3 with odds ratio 1.93 [1.13-3.30]). Based on risk classification improvement measures, FEV1/Ht3 and FEV1Q performed better than FEV1PP.
Conclusion: In a cohort of adults aged 80 and older, FEV1 expressions that are independent of reference values (FEV1/Ht3 and FEV1Q) were better at predicting adverse health outcomes than traditional expressions that depend on reference values, and should be used in further research on FEV1 and aging.
Keywords: FEV1 expressions; adults aged 80 and older; adverse health outcomes.
Copyright © 2016 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Short-term prognostic value of forced expiratory volume in 1 second divided by height cubed in a prospective cohort of people 80 years and older.BMC Geriatr. 2015 Feb 25;15:15. doi: 10.1186/s12877-015-0013-4. BMC Geriatr. 2015. PMID: 25888051 Free PMC article.
-
Prognostic value of short-term decline of forced expiratory volume in 1 s over height cubed (FEV1/Ht3) in a cohort of adults aged 80 and over.Aging Clin Exp Res. 2018 May;30(5):507-516. doi: 10.1007/s40520-017-0792-x. Epub 2017 Jun 26. Aging Clin Exp Res. 2018. PMID: 28653254
-
Correlates of dyspnoea and its association with adverse outcomes in a cohort of adults aged 80 and over.Age Ageing. 2017 Nov 1;46(6):994-1000. doi: 10.1093/ageing/afx095. Age Ageing. 2017. PMID: 28633384
-
Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD.Eur Respir J. 2013 Apr;41(4):800-5. doi: 10.1183/09031936.00008812. Epub 2012 Jul 12. Eur Respir J. 2013. PMID: 22790922
-
Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies.BMJ Open. 2019 Jun 27;9(6):e028150. doi: 10.1136/bmjopen-2018-028150. BMJ Open. 2019. PMID: 31248928 Free PMC article.
Cited by
-
Influences of Two FEV1 Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients.Int J Chron Obstruct Pulmon Dis. 2022 Sep 2;17:2053-2065. doi: 10.2147/COPD.S373834. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36081764 Free PMC article.
-
How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?Am J Mens Health. 2020 May-Jun;14(3):1557988320922630. doi: 10.1177/1557988320922630. Am J Mens Health. 2020. PMID: 32475199 Free PMC article.
-
An updated comparison of standard and novel FEV1 indices' association with all-cause mortality.PLoS One. 2025 May 15;20(5):e0323681. doi: 10.1371/journal.pone.0323681. eCollection 2025. PLoS One. 2025. PMID: 40373056 Free PMC article.
-
FEV1Q: a race-neutral approach to assessing lung function.Eur Respir J. 2024 Apr 4;63(4):2301622. doi: 10.1183/13993003.01622-2023. Print 2024 Apr. Eur Respir J. 2024. PMID: 38485146 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous